NCT00000318View on ClinicalTrials.gov

Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1

PHASE2CompletedINTERVENTIONAL
Enrollment

202

Participants

Timeline

Start Date

December 31, 1994

Primary Completion Date

March 31, 2004

Study Completion Date

August 31, 2007

Conditions
Opioid-Related DisordersSubstance-Related Disorders
Interventions
DRUG

Buprenorphine

"1. Experimental Maintenance treatment with daily medication~2. Experimental Maintenance treatment with thrice-weekly medication"

Trial Locations (1)

06519

APT Residential Services Division, New Haven

All Listed Sponsors
collaborator

Yale University

OTHER

lead

National Institute on Drug Abuse (NIDA)

NIH